SKP2 and cancer: Tsai et al. reported that the E3 ubiquitin-ligase S-phase kinase-associated protein-2 (Skp2) can promote DAB2IP N-terminal ubiquitination and proteasome-mediated degradation in normal and cancer prostate cells [77].